EUVIMEDEUVIMED entdecken
Open Access

High-Cholesterol Diet in Combination With Hydroxypropyl-β Cyclodextrin Induces NASH-Like Disorders in the Liver of Rats

Y Saigo, T Sasase, M Tohma, K Uno, Y Shinozaki, T Maekawa, R Sano, K Miyajima, T Ohta

Physiological Research · 2023

DOI: 10.33549/physiolres.934981 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Physiological Research, 2023. Verfasst von Y Saigo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Biological/Pharmacological Research Laboratories, Takatsuki Research Center, Central Pharmaceutical Research Institute, Japan Tobacco Inc., Takatsuki…. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Hypercholesterolemia, Hyperlipidemias. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non-alcoholic fatty liver disease (NAFLD) is a general term for fatty liver disease not caused by viruses or alcohol. Fibrotic hepatitis, cirrhosis, and hepatocellular carcinoma can develop. The recent increase in NAFLD incidence worldwide has stimulated drug development efforts. However, there is still no approved treatment. This may be due in part to the fact that non-alcoholic steatohepatitis (NASH) pathogenesis is very complex, and its mechanisms are not well understood. Studies with animals are very important for understanding the pathogenesis. Due to the close association between the establishment of human NASH pathology and metabolic syndrome, several animal models have been reported, especially in the context of overnutrition. In this study, we investigated the induction of NASH-like pathology by enhancing cholesterol absorption through treatment with hydroxypropyl-β-cyclodextrin (CDX). Female Sprague-Dawley rats were fed a normal diet with normal water (control group); a high-fat (60 kcal%), cholesterol (1.25 %), and cholic acid (0.5 %) diet with normal water (HFCC group); or HFCC diet with 2 % CDX water (HFCC+CDX group) for 16 weeks. Compared to the control group, the HFCC and HFCC+CDX groups showed increased blood levels of total cholesterol, aspartate aminotransferase, and alanine aminotransferase. At autopsy, parameters related to hepatic lipid synthesis, oxidative stress, inflammation, and fibrosis were elevated, suggesting the development of NAFLD/NASH. Elevated levels of endoplasmic reticulum stress-related genes were evident in the HFCC+CDX group. In the novel rat model, excessive cholesterol intake and accelerated absorption contributed to NAFLD/NASH pathogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseHypercholesterolemiaHyperlipidemiasHumansRatsFemaleAnimals2-Hydroxypropyl-beta-cyclodextrinRats, Sprague-DawleyDiet, High-FatLiverCholesterolDisease Models, Animal

Substanzen

2-Hydroxypropyl-beta-cyclodextrinCholesterol

Autor:innen und Institutionen

  • Biological/Pharmacological Research Laboratories, Takatsuki Research Center, Central Pharmaceutical Research Institute, Japan Tobacco Inc., Takatsuki, Osaka, Japan. tomohiko.sasase@jt.com.

Zitieren

APA

Saigo, Y., Sasase, T., Tohma, M., Uno, K., Shinozaki, Y., Maekawa, T., Sano, R., Miyajima, K., & Ohta, T. (2023). High-Cholesterol Diet in Combination With Hydroxypropyl-β Cyclodextrin Induces NASH-Like Disorders in the Liver of Rats. Physiological Research. https://doi.org/10.33549/physiolres.934981

Vancouver

Saigo Y, Sasase T, Tohma M, Uno K, Shinozaki Y, Maekawa T, et al. High-Cholesterol Diet in Combination With Hydroxypropyl-β Cyclodextrin Induces NASH-Like Disorders in the Liver of Rats. Physiological Research. 2023. doi:10.33549/physiolres.934981

BibTeX
@article{Saigo2023,
  author = {Saigo, Y and Sasase, T and Tohma, M and Uno, K and Shinozaki, Y and Maekawa, T and Sano, R and Miyajima, K and Ohta, T},
  title = {High-Cholesterol Diet in Combination With Hydroxypropyl-β Cyclodextrin Induces NASH-Like Disorders in the Liver of Rats},
  journal = {Physiological Research},
  year = {2023},
  doi = {10.33549/physiolres.934981}
}
Kostenlos starten →